drugset / Trial / NCT01958775
Regulation of Intestinal and Hepatic Lipoprotein Production by Glucagon Like Peptide 2
RandomizedCrossoverSingle-blindBasic science
Summary
1. To assess whether Glucagon like peptide 2 (GLP-2) affects lipoprotein production (study A) 2. To assess whether GLP-2 affects the release of preformed chylomicrons (study B)
Timeline
- Start
- 2012-03
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GLUCAGON-LIKE PEPTIDE II | Peptide | 1500 ug | Subcutaneous |